News Center
February 12, 2022
Technology-Driven Precision Medicine Company Variantyx Secures $41.5M in Funding
- By Variantyx
- Posted in General Company Updates
Funding Round is Led by New Era Capital Partners and Includes Peregrine Ventures, Robert Bosch Venture Capital, 20/20 HealthCare Partners,...
November 12, 2021
Variantyx and Robert-Bosch Hospital team up to improve personalized oncology treatment
- By STUTTGART
- Posted in General Company Updates
STUTTGART, Germany, Nov. 15, 2021 PRNewswire Robert Bosch Venture Capital GmbH, the corporate venture capital company of the Bosch Group, has...
May 11, 2021
Variantyx Expands Into Prenatal, Cancer Testing
- By Variantyx
- Posted in General Company Updates
Genomeweb | May 11, 2021 Variantyx, a genetic testing company offering clinical whole-genome sequencing-based assays, is expanding its menu to...
March 15, 2021
Variantyx Secures $20M in Funding for Whole Genome Sequencing Methodology, Advanced Testing Method that Diagnoses Genetic Disorders
- By Variantyx
- Posted in General Company Updates
March 15, 2021 Variantyx, a leader in high complexity hereditary disease testing, today announced that they secured $20M in funding...